Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.

Journal: Medical archives (Sarajevo, Bosnia and Herzegovina)
PMID: 28210014

Abstract

INTRODUCTION: Anemia occurs in 60% to 80 % of patients with newly diagnosed myeloma multiplex (MM). The cause of anemia in MM is probably multi factorial and involved among the others hepcidin and some cytokines, especially interleukine-6. Anemia in MM is one of the risk factor used in Durie-Salmon classification for staging and prognostic score. Treatment options are set according to this score with most significant impact on survival.

Authors

  • Lejla Ibricevic-Balic
    Clinical center of Sarajevo University, Sarajevo, Bosnia and Herzegovina.
  • Emina Icindic-Nakas
    Faculty of medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Sabaheta Hasic
    Faculty of medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Emina Kiseljakovic
    Faculty of medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Alma Sofo-Hafizovic
    Clinical center of Sarajevo University, Sarajevo, Bosnia and Herzegovina.
  • Sefkija Balic
    Clinical center of Sarajevo University, Sarajevo, Bosnia and Herzegovina.

Keywords

External Resources

Popular Topics
Recent Journals